Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mativ’s healthcare division—primarily through its subsidiary Scapa Healthcare—offers commercialized advanced wound care solutions including FDA-cleared glycopolymer-based cleansers/hydrogels that disrupt biofilms, reduce infection/inflammation/scarring, as well as hydrogel/hydrocolloid dressings. These are supplied to leading MedTech companies globally. The company acts mainly as a contract developer/manufacturer with broad regulatory experience supporting international market access.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mativ.